Gene: SMAD2
Official Full Name: SMAD family member 2provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signal of the transforming growth factor (TGF)-beta, and thus regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation. This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01368 | SMAD2 Knockout cell line (HeLa) | Human | SMAD2 | 1:3~1:6 | Negative | Online Inquiry |
KO09852 | SMAD2 Knockout cell line (HCT 116) | Human | SMAD2 | 1:2~1:4 | Negative | Online Inquiry |
KO09853 | SMAD2 Knockout cell line (HEK293) | Human | SMAD2 | 1:3~1:6 | Negative | Online Inquiry |
KO09854 | SMAD2 Knockout cell line (A549) | Human | SMAD2 | 1:3~1:4 | Negative | Online Inquiry |
SMAD2 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to lack the expression of the SMAD2 gene, which is a critical component of the Transforming Growth Factor Beta (TGF-β) signaling pathway. This product serves as a crucial tool for researchers intent on elucidating the role of SMAD2 in various cellular processes, including cell proliferation, differentiation, and apoptosis.
The primary mechanism by which these knockout cell lines operate involves the deletion of the SMAD2 gene, thereby allowing scientists to investigate the resulting phenotypic changes in the absence of SMAD2-mediated signal transduction. By utilizing these cell lines, researchers can dissect the intricate pathways involved in TGF-β signaling, providing insights into developmental biology, cancer research, and fibrotic diseases.
The scientific importance of SMAD2 Gene Knockout Cell Lines is profound, especially in research environments focused on understanding cellular responses to growth factors and cytokines. These cell lines enable experimental designs that can unveil pathological mechanisms underlying various diseases, from cancer metastasis to fibrosis, thereby opening avenues for targeted therapies.
Compared to alternative models, such as wild-type cell lines or less specific knockout models, SMAD2 Gene Knockout Cell Lines offer a precise and clean experimental approach. This specificity reduces the risk of confounding factors, ensuring that observed effects can be directly attributed to the absence of SMAD2, thus enhancing the reliability of research outcomes.
For researchers and clinicians, the value of these cell lines extends beyond mere functionality. They provide a robust platform for rigorous scientific investigations, potentially leading to groundbreaking discoveries in therapeutic settings. Our company prides itself on its expertise in developing high-quality, genetically engineered biological products. By prioritizing precision and reliability, we are committed to meeting the evolving needs of the scientific community, offering tools that empower researchers to advance their work with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.